News and Events
News and Events
You may sort news and events by title or recency. If you wish to view only news, please select the news link from the left. If you wish to see events at which Quintiles is scheduled to participate, please select the events link from the left.
- Sort by: Most Recent
- Title
-
QUINTILES TRANSNATIONAL FORMS NEW OWNERSHIP TEAM WITH CURRENT INVESTORS GILLINGS, TPG AND TEMASEK JOINED BY BAIN CAPITAL
December 21, 2007 – Quintiles Transnational Corp. today announced the formation of a new investor partnership to support the company’s continued growth under the leadership of current Chairman and CEO Dennis Gillings, CBE, and the management team. Gillings and global private investment firms Bain Capital and TPG Capital are the lead investors in the partnership, with 3i also becoming a significant investor. Temasek Holdings remains an investor in Quintiles. -
QUINTILES APPOINTS JOHN GOODACRE AS GENERAL COUNSEL
December 11, 2007 – Quintiles Transnational Corp. today announced the appointment of John Goodacre as Executive Vice President and General Counsel. -
FORCELOGIX, INNOVEX WIN SALES OPERATIONAL PERFORMANCE AWARD
Nov. 12, 2007 – ForceLogix and Innovex have received the Ventana Research 2007 Operational Performance Leadership Award for Sales, honoring the companies’ combined excellence in orchestrating people, process, information and technology for optimal sales business impact. -
QUINTILES CONSULTING ENTERS RESEARCH PARTNERSHIP
November 7, 2007 – Quintiles Consulting, a leading provider of product development, regulatory and market strategies to the pharmaceutical, biotech and medical device industries, today announced a new research partnership with the Institute for Life Sciences Business Economics (iLSBE) at the Erasmus University of Rotterdam. -
QUINTILES ACQUIRES CENTRAL AMERICAN RESEARCH ORGANIZATION
October 30, 2007 – Quintiles Transnational Corp. today announced that its Latin American subsidiary has purchased Bio-Trials, a leading Central American Clinical Research Organization (CRO) with headquarters in Panama and offices in Costa Rica, Guatemala, Ecuador and Peru. -
EXPERT CARDIOLOGIST JOINS QUINTILES MEDICAL GROUP
October 26, 2007 – Quintiles Transnational Corp. today announced that Christopher H. Cabell, M.D., MHS, FACC, an expert cardiologist and clinical investigator, has joined the Medical & Scientific Services group in Global Clinical Development Services (CDS). In addition to his CDS work, he provides U.S.-based cardiology expertise for Quintiles ECG Services. -
QUINTILES APPOINTS JAY D. NORMAN TO EXPAND CONSULTING BUSINESS
October 8, 2007 – Quintiles Transnational Corp. today announced the appointment of Jay D. Norman to serve as President of its expanding Quintiles Consulting business, which helps pharmaceutical, biotech and medical device companies maximize potential and minimize risk from early discovery through commercialization. -
MICHAEL TROULLIS APPOINTED CHIEF FINANCIAL OFFICER OF QUINTILES TRANSNATIONAL CORP.
August 15, 2007 – Quintiles Transnational Corp. today announced the appointment of Michael Troullis as its Chief Financial Officer, effective immediately. Troullis had been acting CFO since former CFO John Ratliff was appointed Quintiles’ Chief Operating Officer last year. -
QUINTILES TO ADD JOBS, CONSOLIDATE ATLANTA FACILITIES
July 5, 2007 – Quintiles Transnational Corp. today announced plans to expand and consolidate its Global Central Laboratories in Smyrna, Ga., and its Clinical Development Services (CDS) office in Atlanta within a single structure in nearby Marietta, Ga. -
INVESTIGATORS REPORT STRONGER RELATIONSHIPS WITH QUINTILES THAN ANY OTHER CRO
June 21, 2007 – Quintiles Transnational Corp. today announced that clinical investigators rate their relationships with Quintiles the best in the industry, according to a recent survey.